Search

Report from the WHO Regional Office for Europe and the Global Antimicrobial Resistance Research and Development Hub, published 26 May 2025, on advancing the evidence for using bacteriophages against antimicrobial resistance under a One Heal

Armata Pharmaceuticals reported positive topline results from its randomized, placebo-controlled Phase 1b/2a diSArm trial (n=50) of intravenous multi-phage therapeutic AP-SA02 plus best available antibiotic therapy in complicated Staphyloco

Researchers at the Center for Phage Biology and Therapy at Yale report in Nature Medicine on nine adults with cystic fibrosis treated by nebulization with phages selected to kill infecting bacteria and also weaken the survivors, making them

The Online Citizen wrote a piece on Singapore General Hospital's successful use of phage therapy to treat a patient using phages, which allowed the patient to avoid high-risk surgery.

BiomX announced positive topline safety and efficacy results from its Phase 2 DANCE trial of the BX211 phage treatment for diabetic foot osteomyelitis associated with Staphylococcus aureus. BX211 was safe and well tolerated and produced a s

A Future Market Insights press release projects the global bacteriophage market rising from USD 49 million in 2025 to USD 72.4 million by 2035, a 4.0% CAGR. It points to bacteriophage therapy as an alternative to antibiotics and to phage-ba

Andrea Kwa (Singapore General Hospital) and colleagues have announced Singapore’s second phage therapy case.

Micreos Pharmaceuticals partners with biologics CDMO Northway Biotech for its engineered endolysin therapeutic manufacturing program. The partnership will develop scalable cGMP production processes for MEndoB, an investigational therapeutic

Cytophage Technologies announced the development of a phage-based vaccine for avian influenza (H5N1). Two candidates that use filamentous bacteriophages to display influenza antigens are entering preclinical validation, where a pilot study

CRISPRi-ART uses dCas13d to bind specific phage mRNAs and stop production of the proteins they encode. By shutting off different phage proteins, researchers can identify which are essential for infection and investigate what they do. The me

The Israeli Phage Therapy Center named the newly discovered phage KpRaz1 in memory of Raz Abulafia. The article says the phage could have therapeutic value if it proves effective against bacterial infections. Hebrew University

WHO/Europe fact sheet explaining that therapeutic phages are lytic and highly specific to their bacterial hosts and can be used alone or alongside antibiotics, but are not approved medicines in most countries and are mainly used on compassi

Unfortunately, funding for the Canadian National Microbiology Lab's Phage Science, Therapeutics, and Research (PhageSTAR) program is ending.

A USP memorial remembers Aline Maria da Silva’s work with compost phages and her role in bringing researchers together to launch the Cepid B3 Center for Research in Bacteria and Bacteriophages, where she served as vice-director. Jornal da U

Gerdt Lab’s recent work finds that bacterial metabolites synergize with viruses to shape microbial competition. The research was featured by Phys.org, AZoLifeSciences and ContagionLive. Gerdt Laboratory, Indiana University

Cytophage and Winnipeg’s Orthopaedic Innovation Centre announced Manitoba’s first Phage Clinical Treatment Program, initially focused on prosthetic joint infections resistant to antibiotics. The partners planned compassionate-use/N=1 cases

Technology Networks feature by Blake Forman on how synthetic biology is used to modify antibiotics, improve antibiotic production and engineer more targeted phages, including CRISPR–Cas-armed phages, alongside engineered probiotics and bios

Scientists from the Institut Pasteur, Inserm, AP-HP and Université Paris Cité trained an AI model that recommends a phage cocktail for a bacterial strain from its genome alone, using 350,000 interactions between 403 E. coli strains and 96 p

Anthony King wrote a piece for Nature Outlook on bacteria-killing viruses in the gut microbiome, showing that phages are key players in gut ecology but remain difficult to study due to their abundance and diversity.

On 15 November 2024 the board of Portugal's medicines authority INFARMED approved, in Deliberação n.º 112/CD/2024, a guidance note on compounded medicines for phage therapy in hospitals: magistral preparations of bacteriophages made in a ho